MedPath

Web-Mediated Risk Assessment for Endoscopic Screening of Gastric Cancer

Not Applicable
Conditions
Gastric Cancer
Interventions
Diagnostic Test: pre-endoscopic screening risk assessment
Registration Number
NCT03484949
Lead Sponsor
State Key Laboratory of Cancer Biology
Brief Summary

Gastric cancer is one of the most common malignancies in China. Early detection is critical for gastric cancer management. However, the diagnosis rate of patients with early gastric cancer is still low. Therefore, the investigator design this study to access whether pre-endoscopic screening risk assessment of genetic and environmental risk factors could improve early gastric cancer diagnosis rate.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
1000
Inclusion Criteria
  • 1.Age 18-60. 2.Signed informed consent
Exclusion Criteria
  • 1.Severe back ground disease including malignancy. 2.State after gastric surgery. 3.COPD, CHF, CRF and any disease with respiratory disturbances. 4.Deviation of the nasal septum, lack of venous access at the dorsum of the hand or any other technical problem prevents gastric acid collection or base excess evaluation.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
pre-endoscopic screening risk assessmentpre-endoscopic screening risk assessment-
Primary Outcome Measures
NameTimeMethod
Diagnostic rate of patients with early gastric cancer2020

Diagnostic rate of patients with early gastric cancer

Secondary Outcome Measures
NameTimeMethod
Characterization of the high-rik individual for gastric cancer2020

Diagnostic rate of patients with early gastric cancer

Trial Locations

Locations (1)

Dake Chu

🇨🇳

Xi'an, Shaanxi, China

© Copyright 2025. All Rights Reserved by MedPath